Ignite Creation Date:
2025-12-24 @ 10:49 PM
Ignite Modification Date:
2026-05-05 @ 1:34 PM
Study NCT ID:
NCT06678269
Status:
RECRUITING
Last Update Posted:
2025-09-05
First Post:
2024-11-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Metastatic Breast Cancer | View |
| None | Stage IV Breast Cancer | View |
| None | Breast Cancer | View |
| None | Breast Cancer Stage IV | View |
| None | Breast Cancer Metastatic | View |
| None | HER2-negative Breast Cancer | View |
| None | HER2 Negative Breast Carcinoma | View |
| None | Hormone-receptor-positive Breast Cancer | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Metastatic Breast Cancer | View |
| None | Stage IV Breast Cancer | View |
| None | Breast Cancer | View |
| None | Breast Cancer Stage IV | View |
| None | Breast Cancer Metastatic | View |
| None | HER2-negative Breast Cancer | View |
| None | HER2 Negative Breast Carcinoma | View |
| None | Hormone-receptor-positive Breast Cancer | View |
| None | Memorial Sloan Kettering Cancer Center | View |
| None | 24-138 | View |